Department of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, Qingdao, China.
J Alzheimers Dis. 2012;29(3):515-9. doi: 10.3233/JAD-2011-111844.
Variants in the clusterin gene have been associated with Alzheimer's disease (AD) through replicated genome-wide studies, but the underlying mechanisms remain unknown. In this study the association of the AD clusterin common risk polymorphism rs9331888 with blood clusterin levels was tested in 104 AD subjects and 104 healthy controls. Blood clusterin levels were significantly elevated in AD patients (p < 0.05). The rs9331888 AD-risk variant was associated with low clusterin mRNA and protein levels in an allele-dose dependent manner in both groups (p < 0.001). This study indicates that the rs9331888 AD-risk variant is associated with low blood clusterin levels.
该簇蛋白基因的变异与通过复制全基因组研究的阿尔茨海默病(AD)相关,但潜在的机制仍然未知。在这项研究中,簇蛋白常见风险多态性 rs9331888 与 104 例 AD 患者和 104 例健康对照者的血液簇蛋白水平的关联进行了检测。AD 患者的血液簇蛋白水平显著升高(p < 0.05)。rs9331888 AD 风险变异与两组中簇蛋白 mRNA 和蛋白水平的等位基因剂量依赖性降低相关(p < 0.001)。本研究表明,rs9331888 AD 风险变异与低血液簇蛋白水平相关。